Lucintel Forecasts the Global HumiraBiosimilar Market is expected to grow with a CAGR of 26.0% from 2024 to 2030
Lucintel Forecasts the Global HumiraBiosimilar Market is expected to grow with a CAGR of 26.0% from 2024 to 2030
Blog Article
According to a market report by Lucintel, the future of the global humirabiosimilar market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global humirabiosimilar market is expected to grow with a CAGR of 26.0% from 2024 to 2030. The major drivers for this market are growing prevalence of autoimmune diseases, rising pharmaceutical firms to develop and commercialize biosimilar versions of humira, since the expiration of the patents protecting humira paved the path for the entry of biosimilars, and biosimilars provide a more affordable alternative to the reference biologic medicine.
A more than 150-page report to understand trends, opportunity and forecast in humirabiosimilar market to 2030 by product type (biosimilarhumira (adalimumab) and interchangeable biosimilarhumira), patient age (adult patients, pediatric patients, and geriatric patients), indication (rheumatoid arthritis, psoriasis, crohn's disease, ulcerative colitis, ankylosing spondylitis, juvenile idiopathic arthritis, and others), distribution channel (hospital pharmacies, retail pharmacies, online pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)
Lucintel forecasts that, within the product type category, biosimilarhumira (adalimumab) will remain the larger segment over the forecast period.
Within the distribution channel category, hospital pharmacy will remain the largest segment.
Download sample by clicking on humirabiosimilar market
In terms of regions, North America will remain the largest region over the forecast period due to the expiration of humiraÄX%$%Xs patents, the market for biosimilars is projected to expand in the region.
Amgen, Samsung Bioepis, Sandoz International, Mylan, BoehringerIngelheim International, copyright, Fresenius Kabi, CoherusBioSciences, Biogen, AbbVieare the major suppliers in the humirabiosimilar market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.comTo get access of more than 1000 reports at fraction of cost visit Lucintel'sAnalytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market &unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Urethane Adhesive Market
Titanate Praseodymium Target Market
Tungsten Electrode Market
Digital Agriculture Market
Sustainable Agriculture Market